Vaš brskalnik ne omogoča JavaScript!
JavaScript je nujen za pravilno delovanje teh spletnih strani. Omogočite JavaScript ali pa uporabite sodobnejši brskalnik.
Repozitorij Univerze v Ljubljani
Nacionalni portal odprte znanosti
Odprta znanost
DiKUL
slv
|
eng
Iskanje
Napredno
Novo v RUL
Kaj je RUL
V številkah
Pomoč
Prijava
Podrobno
Syndromic molecular testing in mechanically ventilated patients with severe pneumonia : a supportive diagnostic approach
ID
Uršič, Tina
(
Avtor
),
ID
Erzar, Kaja
(
Avtor
),
ID
Seme, Katja
(
Avtor
),
ID
Jereb, Matjaž
(
Avtor
),
ID
Strle, Franc
(
Avtor
),
ID
Petrovec, Miroslav
(
Avtor
)
PDF - Predstavitvena datoteka,
prenos
(501,03 KB)
MD5: 07518E6770D3E3BDFCAFA07D753B9DDD
URL - Izvorni URL, za dostop obiščite
https://journals.asm.org/doi/10.1128/spectrum.02155-25
Galerija slik
Izvleček
Rapid identification of pathogens is critical in severe pneumonia patients for timely therapy in mechanically ventilated intensive care unit patients. Conventional diagnostics are time-consuming. The Allplex Respiratory Panels 1-4 detect 16 viruses and seven bacteria and provide faster results; however, because this molecular assay does not yield viable organisms, antimicrobial susceptibility testing cannot be performed. We compared conventional diagnostics with commercial panels to evaluate diagnostic performance and clinical utility. In this prospective study, a total of 30 bronchoalveolar lavage fluids and 80 tracheal aspirates were obtained from 110 unique ICU patients with severe pneumonia (January 2014 and April 2016). Conventional diagnostics were performed during illness, whereas testing of these specimens by commercial panels was performed retrospectively. Pathogen detection rates and co-detections were analyzed by pneumonia type (community-acquired, hospital-acquired, and ventilator-associated). Conventional diagnostics detected pathogens in 87 of 110 patients (79.1%) versus 70 of 110 (63.6%) detected by the commercial approach (P = 0.016). Detection of viruses was most frequent, predominantly influenza A and human rhinoviruses; common bacterial detections included Haemophilus influenzae, Legionella pneumophila, and Streptococcus pneumoniae. Co-detections occurred in 12.7% patients by the commercial approach and in 21.8% by the conventional approach, including virus-bacterium co-detections in 10.9% and 14.5% of cases, respectively. The commercial approach missed eight bacterial and four fungal detections identified by conventional methods. Conventional diagnostics showed higher yield in hospital-acquired pneumonia (82.5% vs 50.0%; P = 0.004), whereas both approaches were comparable in community-acquired cases (75% vs 73.4%). Conventional diagnostics (including culture-based methods) provide broader detection and offer the ability for phenotypic antimicrobial susceptibility testing to be performed, whereas commercial panels offer speed; together, they may optimize pathogen detection and therapy in critically ill patients.IMPORTANCESevere pneumonia in critically ill patients remains a major clinical challenge due to its diverse etiology, rapid progression, and the need for timely, targeted therapy. This study demonstrates that conventional diagnostic approaches-combining culture and molecular tests-identify the etiology more effectively than a commercial multiplex PCR-based syndromic panel in ICU patients. While the molecular approach offers faster results, it lacks the breadth of bacterial and fungal targets and does not provide the opportunity for antimicrobial susceptibility testing. Importantly, viral pathogens-particularly influenza A and rhinoviruses-were frequently detected, underscoring their role in severe pneumonia and the relevance of viral-bacterial co-infections. This work highlights that syndromic molecular diagnostics may be valuable for rapid screening or in community-acquired pneumonia but are insufficient for hospital- or ventilator-associated pneumonia. Our findings support a complementary diagnostic strategy to optimize pneumonia management in ICU settings, improve antimicrobial stewardship, and ultimately impact clinical outcomes for patients with life-threatening respiratory infections.
Jezik:
Angleški jezik
Ključne besede:
bacteria
,
fungi
,
intensive care unit
,
molecular methods
,
severe pneumonia
,
viruses
Vrsta gradiva:
Članek v reviji
Tipologija:
1.01 - Izvirni znanstveni članek
Organizacija:
MF - Medicinska fakulteta
Status publikacije:
Objavljeno
Različica publikacije:
Objavljena publikacija
Leto izida:
2026
Št. strani:
16 stra.
Številčenje:
Vol. 14, iss. 1, art. e0215525
PID:
20.500.12556/RUL-177860
UDK:
616.9:579
ISSN pri članku:
2165-0497
DOI:
10.1128/spectrum.02155-25
COBISS.SI-ID:
260338435
Datum objave v RUL:
13.01.2026
Število ogledov:
503
Število prenosov:
138
Metapodatki:
Citiraj gradivo
Navadno besedilo
BibTeX
EndNote XML
EndNote/Refer
RIS
ABNT
ACM Ref
AMA
APA
Chicago 17th Author-Date
Harvard
IEEE
ISO 690
MLA
Vancouver
:
Kopiraj citat
Objavi na:
Gradivo je del revije
Naslov:
Microbiology spectrum
Skrajšan naslov:
Microbiol. spectr.
Založnik:
American society for Microbiology
ISSN:
2165-0497
COBISS.SI-ID:
4526968
Licence
Licenca:
CC BY 4.0, Creative Commons Priznanje avtorstva 4.0 Mednarodna
Povezava:
http://creativecommons.org/licenses/by/4.0/deed.sl
Opis:
To je standardna licenca Creative Commons, ki daje uporabnikom največ možnosti za nadaljnjo uporabo dela, pri čemer morajo navesti avtorja.
Sekundarni jezik
Jezik:
Slovenski jezik
Ključne besede:
bakterije
,
glive
,
enota intenzivne nege
,
molekularne metode
,
huda pljučnica
,
virusi
Projekti
Financer:
ARIS - Javna agencija za znanstvenoraziskovalno in inovacijsko dejavnost Republike Slovenije
Številka projekta:
P3-0083
Naslov:
Odnosi parazitskega obstajanja
Podobna dela
Podobna dela v RUL:
Podobna dela v drugih slovenskih zbirkah:
Nazaj